ArticleBreast (Edinburgh, Scotland)2022

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer.

Mythili Shastry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.